Comment
Author: Admin | 2025-04-28
The following applies to the ingredients: Alprazolam (found in Xanax) This drug is only recommended for use during pregnancy when there are no alternatives and the benefit outweighs the risk, especially during the first trimester of pregnancy.AU TGA pregnancy category: CUS FDA pregnancy category: Not assigned.Risk Summary: Use may be associated with an increased risk of congenital malformations. There are no adequate studies of this drug in pregnant women to inform a drug-related risk.Comments:-The child born to a mother taking benzodiazepines may be at risk for withdrawal symptoms.-Benzodiazepines may cause fetal harm when administered during pregnancy.-The patient should be warned of the potential risks to the fetus and instructed to discontinue the drug prior to becoming pregnant.-A pregnancy exposure registry is available.Several studies have suggested an increased risk of congenital malformations associated with the use of minor tranquilizers (i.e., chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy. There are no controlled data in human pregnancy.To monitor maternal-fetal outcome of pregnant women exposed to antiepileptic drugs, the North American Antiepileptic Drug (NAAED) Pregnancy Registry has been established. Healthcare providers are encouraged to prospectively register patients. For additional information: http://www.aedpregnancyregistry.org/AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details.US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products
Add Comment